Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA229068 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Expression data from melanoma subpopulations
2025-01-24 | E-GEOD-36035 | ExpressionAtlas
Project description:Expression Data from Uveal Melanoma primary tumors.
| PRJNA127577 | ENA
Project description:Whole-transcript expression data for uveal melanoma
| PRJNA148641 | ENA
Project description:Whole-transcript expression data of BRD4 inhibition in uveal melanoma
| PRJNA275786 | ENA
Project description:uveal melanoma cells Transcriptome or Gene expression
| PRJNA190187 | ENA
Project description:Expression Data from Uveal Melanoma patient-derived xenograft and tumor of origin
| PRJNA312390 | ENA
Project description:Gene expression analysis of uveal melanoma tumor tissue
| PRJNA171547 | ENA
Project description:Expression data from BRAFV600E A375 melanoma cells treated with vehicle or vemurafenib
2025-01-24 | E-GEOD-42872 | ExpressionAtlas
Project description:RNA extracted at 240min. Samples are rRNA depleted. Expression measurement of Homo sapiens genes.
2019-07-31 | GSE114179 | GEO
Project description:Metastatic uveal melanoma is an aggressive disease with limited effective therapeutic options. To comprehensively map monogenic and digenic dependencies, we performed CRISPR-Cas9 screening in ten extensively profiled human uveal melanoma cell line models using genome-wide single gene/gRNA and combinatorial paired gene/paired gRNA CRISPR libraries. Within our identified uveal melanoma-specific essential genes and synthetic lethal gene pairs, we identified and validated CDS2 as a novel genetic dependency in the context of low CDS1 expression. We further demonstrate that CDS1/CDS2 is a synthetic lethal interaction in vivo and reveal that CDS2 knockout results in the disruption of phosphoinositide synthesis, cellular apoptosis, and that re-expression of CDS1 rescues the cell fitness defect provoked by CDS2 loss. We extend our analysis using pan-cancer data confirming increased CDS2 essentiality in diverse tumour types with low CDS1 expression. Our results suggest that CDS2 inhibition should be investigated as a therapeutic strategy in uveal melanoma that may extend to multiple tumour types with low CDS1 expression. The data provided in this dataset explore the effect of CDS2 loss in uveal melanoma cell lines.
2025-04-01 | PXD053752 | Pride